Serum Oxidized Albumin and Cardiovascular Mortality in Normoalbuminemic Hemodialysis Patients: A Cohort Study

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Lim, Paik Seong ^a,b   Jeng, Yachung ^a   Wu, Ming Ying ^a   Pai, Mei Ann ^a   Wu, Tsai Kun ^a   Liu, Chia San ^a   Chen, Chan Hsu ^a   Kuo, Yuan Chuan ^a   Chien, Shiaw Wen ^a   Chen, Hung Ping ^a  

^a TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^b PROVIDENCE UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ALBUMIN BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PROTEIN FUNCTION; RISK ASSESSMENT; SURVIVAL;

ADOLESCENT; ADULT; AGED; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SERUM ALBUMIN; YOUNG ADULT;

EID: 84880817911     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070822     Document Type: Article

References (44)

1. Foley RN, Parfrey PS, Sarnak MJ (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis (suppl 3): S112-S119.
2. Levin A, Singer J, Thompson CR, Ross H, Lewis M, (1996) Prevalent LVH in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis 27: 347-354.
3. Descamps-Latscha B, Witko-Sarsat V (2001) Importance of oxidatively modified proteins in chronic renal failure. Kidney Int (Suppl 78): S108-S113.
4. Daschner M, Lenhartz H, Bötticher D, Schaefer F, Wollschläger M, el al, (1996) Influence of dialysis on plasma lipid peroxidation products and antioxidant levels. Kidney Int 50: 1268-1272.
5. Halliwell B, (1988) Albumin- an important extracellular antioxidant? Biochem Pharmacol 37: 569-571.
6. Peters T Jr (1996) All about Albumin: Biochemistry, Genetics, and Medical Applications. San Diego, CA: Academic Press. 51-54.
7. Bourdon E, Loreau N, Blache D, (1999) Glucose and free radicals impair the antioxidant properties of serum albumin. FASEB J 13: 233-244.
8. Dean RT, Hunt JV, Grant AJ, Yamamoto Y, Niki E, (1991) Free radical damage to proteins: The influence of the relative localization of radical generation, antioxidants, and target proteins. Free Radic Biol Med 11: 161-168.
9. Lim PS, Cheng YM, Yang SM, (2007) Impairments of the biological properties of serum albumin in patients on haemodialysis. Nephrology 12: 18-24.
10. Cha MK, Kim IH, (1996) Glutathione-linked thiol peroxidase activity of human serum albumin. Biochem Biophys Res Commun 222: 619-625.
11. Era S, Kuwata K, Imai H, Nakamura K, Hayashi T, et al. (1995) Age-related change in redox state of human serum albumin. Biochim Biophys Acta 1247: 12-16.
12. Hayashi T, Era S, Kawai K, Imai H, Nakamura K, et al. (2000) Observation for redox state of human serum and aqueous humor albumin from patients with senile cataract. Pathophysiology 6: 237-243.
13. Soejima A, Matsuzawa N, Hayashi T, Kimura R, Ootsuka T, et al. (2004) Alteration of redox state of human albumin before and after hemodialysis. Blood Purif 22: 525-529.
14. Terawaki H, Yoshimura K, Hasegawa T, Matsuyama Y, Negawa T, et al. (2004) Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin. Kidney Int 66: 1988-1993.
15. Goldwasser P, Feldman J, (1997) Association of serum albumin and mortality risk. J Clin Epidemiol 50: 693-703.
16. De Mutsert R, Grootendorst DC, Indemans F, Boeschoten EW, Krediet RT, et al. (2009) Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. J Ren Nutr 19: 127-135.
17. Djoussé L, Rothman KJ, Cupples LA, Levy D, Ellison RC, (2002) Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham Offspring Study. Circulation 106: 2919-2924.
18. Ogasawara Y, Mukai Y, Togawa T, Suzuki T, Tanabe S, et al. (2007) Determination of plasma thiol bound to albumin using affinity chromatography and high-performance liquid chromatography with fluorescence detection: ratio of cysteinyl albumin as a possible biomarker of oxidative stress. J Chromatogr B Analyt Technol Biomed Life Sci 845: 157-163.
19. Danielski M, Ikizler TA, McMonagle E, Kane JC, Pupim L, et al. (2003) Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy. Am J Kidney Dis 42: 286-294.
20. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, McAllister CJ, Alcorn H Jr, et al. (2005) Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant 20: 1880-1888.
21. Amaral S, Hwang W, Fivush B, Neu A, Frankenfield D, et al. (2008) Serum albumin level and risk for mortality and hospitalization in adolescents on hemodialysis. Clin J Am Soc Nephrol 3: 759-767.
22. Himmelfarb J, McMonagle E, (2001) Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int 60: 358-363.
23. Mera K, Anraku M, Kitamura K, Nakajou K, Maruyama T, et al. (2005) Oxidation and carboxy methyl lysine-modification of albumin: possible involvement in the progression of oxidative stress in hemodialysis patients. Hypertens Res 28: 973-980.
24. Michelis R, Kristal B, Snitkovsky T, Sela S, (2010) Oxidative modifications impair albumin quantification. Biochem Biophys Res Commun 401: 137-142.
25. Sogami M, Era S, Nagaoka S, Kuwata K, Kida K, et al. (1985) High-performance liquid chromatographic studies on non-mercapt-mercapt conversion of human serum albumin. II. J Chromatogr 332: 19-27.
26. Tomida M, Ishimaru J, Hayashi T, Nakamura K, Murayama K, et al. (2003) The redox states of serum and synovial fluid of patients with temporomandibular joint disorders. Jpn J Physiol 53: 351-355.
27. Terawaki H, Takada Y, Era S, Funakoshi Y, Nakayama K, et al. (2010) The redox state of albumin and serious cardiovascular incidence in hemodialysis patients. Ther Apher Dial 14: 465-471.
28. Sogami M, Era S, Nagaoka S, Kuwata K, Kida K, et al. (1985) HPLC-studies on nonmercapt-mercapt conversion of human serum albumin. Int J Pept Protein Res 25: 398-402.
29. Cooper BA, Penne EL, Bartlett LH, Pollock CA, (2004) Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. Am J Kidney Dis 43: 61-66.
30. Iseki K, Kawazoe N, Fukiyama K, (1993) Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 44: 115-119.
31. Don BR, Kaysen G, (2004) Serum albumin: relationship to inflammation and nutrition. Semin Dial 17: 432-437.
32. Oettl K, Stauber RE (2007) Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br. J. Pharmacol. 151, 580-590.
33. Radi R, Beckman JS, Bush KM, Freeman BA, (1991) Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 266: 4244-4250.
34. Finch JW, Crouch RK, Knapp DR, Schey KL, (1993) Mass spectrometric identification of modifications to human serum albumin treated with hydrogen peroxide. Arch Biochem Biophys 305: 595-599.
35. DeMaster EG, Quast BJ, Redfern B, Nagasawa HT, (1995) Reaction of nitric oxide with the free sulfhydryl group of human serum albumin yields a sulfenic acid and nitrous oxide. Biochemistry 34: 11494-11499.
36. Gatti RM, Radi R, Augusto O, (1994) Peroxynitrite-mediated oxidation of albumin to the protein-thiyl free radical. FEBS Lett 348: 287-290.
37. Thomas JA, Poland B, Honzatko R, (1995) Protein sulfhydryls and their role in the antioxidant function of proteins-thiolation. Arch Biochem Biophys 319: 1-9.
38. Janatova J, Fuller JK, Hunter MJ, (1968) The heterogeneity of bovine albumin with respect to sulfhydryl and dimer content. J Biol Chem 243: 3612-3622.
39. Mera K, Anraku M, Kitamura K, Nakajou K, Maruyama T, et al. (2005) The structure and function of oxidized albumin in hemodialysis patients: its role in elevated oxidative stress via neutrophil burst. Biochem Biophys Res Commun 334: 1322-1328.
40. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM, (2002) The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62: 1524-38.
41. Beddhu S, Kaysen GA, Yan G, Sarnak M, Agodoa L, et al. (2002) Association of serum albumin and atherosclerosis in chronic hemodialysis patients. Am J Kidney Dis 40: 721-7.
42. Kalantar-Zadeh K, Brennan ML, Hazen SL, (2006) Serum myeloperoxidase and mortality in maintenance hemodialysis patients. Am J Kidney Dis 48: 59-68.
43. Roberts MA, Thomas MC, Fernando D, Macmillan N, Power DA, et al. (2006) Low molecular weight advanced glycation end products predict mortality in asymptomatic patients receiving chronic haemodialysis. Nephrol Dial Transplant 21: 1611-1617.
44. Ishii T, Ohtake T, Okamoto K, Mochida Y, Ishioka K, et al. (2011) Serum biological antioxidant potential predicts the prognosis of hemodialysis patients. Nephron Clin Pract 117: c230-6.